We are pleased to offer the following evening workshops at US HUPO 2021:
Interactive Career Planning and Development
Biomarkers for Early Detection
How to Bring the Impact of Multi-omics Research to the Next Level? From Industry and Academic Perspectives
Cardiovascular Proteomics in Translational and Clinical Research: How to Accelerate "Bench-to-Bedside" Translation?
Putting Humpty Dumpty Back Together Again: What Does Protein Quant Mean in Bottom-Up Proteomics?
Top-down Proteomics: Tips and Tricks for Beginners
TaMADOR - Targeted Mass Spectrometric Assays for Diabetes and Obesity Research
The NIDDK recently started a program for developing mass spectrometric assays for proteins and peptides of primary interest to the obesity and diabetes research community. These assays should be highly reproducible, easily transferable to other laboratories, and validated in human plasma or serum. Examples, of proteins and peptides that are of potential interest include insulin, glucagon, c-peptide, glycated CD59, Adiponectin, Leptin, Resistin, Neuropeptide Y, Alpha-melanocyte-stimulating hormone, Peptide YY, Glucagon-like peptide 1, Ghrelin, Adrenocorticotropin, Corticotropin-releasing hormone, Gastrin, , Vasoactive intestinal peptide, gastric-inhibitory peptide, gastrin-releasing peptide, motilin, pancreatic polypeptide, myostatin, and FGF21). We will introduce the TaMADOR (Targeted Mass Spectrometric Assays for Diabetes and Obesity Research) program and discuss how we might proceed in developing, validating, and implementing MS assays of interest to the Obesity and Diabetes community.